Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Polymyxin"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 7212
Tytuł:
Mid-dosing interval concentration is important for polymyxin B exposure and acute kidney injury in critically ill patients.
Autorzy:
Wang J; Department of Pharmacy, Nanjing Drum Tower Hospital the Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Li Y; Department of Pharmacy, China Pharmaceutical University Nanjing Drum Tower Hospital, Nanjing, China.
Huang S; Department of Pharmacy, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.
Wang M; Department of Pharmacy, Nanjing Drum Tower Hospital the Affiliated Hospital of Nanjing University Medical School, Nanjing, China.; Nanjing Medical Center for Clinical Pharmacy, Nanjing, China.
Jin L; Department of Pharmacy, Nanjing Drum Tower Hospital the Affiliated Hospital of Nanjing University Medical School, Nanjing, China.; Nanjing Medical Center for Clinical Pharmacy, Nanjing, China.
Luo X; Department of Pharmacy, Nanjing Drum Tower Hospital the Affiliated Hospital of Nanjing University Medical School, Nanjing, China.; Nanjing Medical Center for Clinical Pharmacy, Nanjing, China.
Cheng X; Jiangsu Qlife Medical Technology Group Co., Ltd., Nanjing, China.
Yang N; Department of Pharmacy, Nanjing Drum Tower Hospital the Affiliated Hospital of Nanjing University Medical School, Nanjing, China.; Nanjing Medical Center for Clinical Pharmacy, Nanjing, China.
Zhu H; Department of Pharmacy, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.; Nanjing Medical Center for Clinical Pharmacy, Nanjing, China.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Dec; Vol. 12 (12), pp. 1911-1921. Date of Electronic Publication: 2023 Sep 17.
Typ publikacji:
Journal Article
MeSH Terms:
Polymyxin B*/adverse effects
Acute Kidney Injury*/chemically induced
Humans ; Critical Illness ; Risk Factors ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Polyphosphate kinase regulates LPS structure and polymyxin resistance during starvation in E. coli.
Autorzy:
Baijal, Kanchi (AUTHOR)
Abramchuk, Iryna (AUTHOR)
Herrera, Carmen M. (AUTHOR)
Mah, Thien-Fah (AUTHOR)
Trent, M. Stephen (AUTHOR)
Lavallée-Adam, Mathieu (AUTHOR)
Downey, Michael (AUTHOR)
Pokaż więcej
Źródło:
PLoS Biology. 3/13/2024, Vol. 22 Issue 3, p1-24. 24p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A pH/enzyme dual responsive PMB spatiotemporal release hydrogel promoting chronic wound repair.
Autorzy:
Dong L; College of Bioengineering, Chongqing University, Chongqing, 400044, People's Republic of China.; Institute of Burn Research, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, People's Republic of China.
Huang C; Institute of Burn Research, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, People's Republic of China.
Zhao B; Institute of Burn Research, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, People's Republic of China.
Hu G; Institute of Burn Research, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, People's Republic of China.
Huang Y; Institute of Burn Research, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, People's Republic of China.
Zhang X; Institute of Burn Research, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, People's Republic of China.
Hu X; Institute of Burn Research, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, People's Republic of China.
Wang Y; Institute of Burn Research, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, People's Republic of China.
XiaoyanSun; Department of Medical Innovation, Research Center for Wound Healing & Regenerative Medicine, Chinese PLA General Hospital, Beijing, 100853, People's Republic of China.
Qian W; Institute of Burn Research, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, People's Republic of China. .
Luo G; Institute of Burn Research, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2023 Jul 07; Vol. 21 (1), pp. 213. Date of Electronic Publication: 2023 Jul 07.
Typ publikacji:
Journal Article
MeSH Terms:
Polymyxin B*/pharmacology
Hydrogels*/chemistry
Wound Healing ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/chemistry ; Anti-Inflammatory Agents/pharmacology ; Hydrogen-Ion Concentration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clonal transmission of polymyxin B-resistant hypervirulent Klebsiella pneumoniae isolates coharboring bla NDM-1 and bla KPC-2 in a tertiary hospital in China.
Autorzy:
Tang M; Department of Clinical Laboratory, Xiangya Hospital, Central South University, No.87 Xiangya Road, Kaifu district, Changsha, Hunan, China.
Li J; Department of Clinical Laboratory, Xiangya Hospital, Central South University, No.87 Xiangya Road, Kaifu district, Changsha, Hunan, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, No.87 Xiangya Road, Kaifu District, Changsha, Hunan, China.
Liu Z; Department of Clinical Laboratory, Xiangya Hospital, Central South University, No.87 Xiangya Road, Kaifu district, Changsha, Hunan, China.
Xia F; Department of Clinical Laboratory, Xiangya Hospital, Central South University, No.87 Xiangya Road, Kaifu district, Changsha, Hunan, China.
Min C; Department of Clinical Laboratory, Xiangya Hospital, Central South University, No.87 Xiangya Road, Kaifu district, Changsha, Hunan, China.
Hu Y; Department of Clinical Laboratory, Xiangya Hospital, Central South University, No.87 Xiangya Road, Kaifu district, Changsha, Hunan, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, No.87 Xiangya Road, Kaifu District, Changsha, Hunan, China.
Wang H; Department of Clinical Laboratory, Xiangya Hospital, Central South University, No.87 Xiangya Road, Kaifu district, Changsha, Hunan, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, No.87 Xiangya Road, Kaifu District, Changsha, Hunan, China.
Zou M; Department of Clinical Laboratory, Xiangya Hospital, Central South University, No.87 Xiangya Road, Kaifu district, Changsha, Hunan, China. .; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, No.87 Xiangya Road, Kaifu District, Changsha, Hunan, China. .
Pokaż więcej
Źródło:
BMC microbiology [BMC Microbiol] 2023 Mar 07; Vol. 23 (1), pp. 64. Date of Electronic Publication: 2023 Mar 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Klebsiella pneumoniae*/drug effects
Klebsiella pneumoniae*/genetics
Polymyxin B*/pharmacology
Drug Resistance, Multiple, Bacterial*
Klebsiella Infections*/microbiology
Klebsiella Infections*/transmission
Humans ; China/epidemiology ; Tertiary Care Centers ; Disease Outbreaks
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Proof-of-concept for incorporating mechanistic insights from multi-omics analyses of polymyxin B in combination with chloramphenicol against Klebsiella pneumoniae.
Autorzy:
Hanafin PO; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Abdul Rahim N; Faculty of Pharmacy, University of Malaya, Kuala Lumpur, Malaysia.
Sharma R; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Cess CG; Department of Biomedical Engineering Viterbi School of Engineering, University of Southern California, Los Angeles, California, USA.
Finley SD; Department of Biomedical Engineering Viterbi School of Engineering, University of Southern California, Los Angeles, California, USA.
Bergen PJ; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Velkov T; Department of Pharmacology and Therapeutics, The University of Melbourne, Melbourne, Victoria, Australia.
Li J; Department of Microbiology, Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences and Biomedicine Discovery Institute, Monash University, Parkville, Victoria, Australia.
Rao GG; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Mar; Vol. 12 (3), pp. 387-400. Date of Electronic Publication: 2023 Feb 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Polymyxin B*/pharmacology
Chloramphenicol*/pharmacology
Chloramphenicol*/metabolism
Humans ; Klebsiella pneumoniae/genetics ; Klebsiella pneumoniae/metabolism ; Multiomics ; Anti-Bacterial Agents/pharmacology ; Microbial Sensitivity Tests
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Polymyxin B Conjugates with Bio-Inspired Synthetic Polymers of Different Nature.
Autorzy:
Dvoretckaia A; Institute of Chemistry, Saint-Petersburg State University, 198504 St. Petersburg, Russia.; Institute of Macromolecular Compounds, Russian Academy of Sciences, 199004 St. Petersburg, Russia.
Egorova T; State Research Institute of Highly Pure Biopreparations FMBA of Russia, 197110 St. Petersburg, Russia.
Dzhuzha A; Institute of Chemistry, Saint-Petersburg State University, 198504 St. Petersburg, Russia.
Levit M; Institute of Macromolecular Compounds, Russian Academy of Sciences, 199004 St. Petersburg, Russia.
Sivtsov E; Institute of Macromolecular Compounds, Russian Academy of Sciences, 199004 St. Petersburg, Russia.; Department of Physical Chemistry, Saint-Petersburg State Institute of Technology (Technical University), 190013 St. Petersburg, Russia.
Demyanova E; State Research Institute of Highly Pure Biopreparations FMBA of Russia, 197110 St. Petersburg, Russia.
Korzhikova-Vlakh E; Institute of Macromolecular Compounds, Russian Academy of Sciences, 199004 St. Petersburg, Russia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jan 17; Vol. 24 (3). Date of Electronic Publication: 2023 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Polymyxin B*/pharmacology
Deferoxamine*
Humans ; Glutamic Acid ; Anti-Bacterial Agents/pharmacology ; Polymers/chemistry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Synergistic Activity and Mechanism of Sanguinarine with Polymyxin B against Gram-Negative Bacterial Infections.
Autorzy:
Qiao, Luyao (AUTHOR)
Zhang, Yu (AUTHOR)
Chen, Ying (AUTHOR)
Chi, Xiangyin (AUTHOR)
Ding, Jinwen (AUTHOR)
Zhang, Hongjuan (AUTHOR)
Han, Yanxing (AUTHOR)
Zhang, Bo (AUTHOR)
Jiang, Jiandong (AUTHOR)
Lin, Yuan (AUTHOR)
Pokaż więcej
Źródło:
Pharmaceutics. Jan2024, Vol. 16 Issue 1, p70. 20p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
热毒宁注射液联合美罗培南和多黏菌素 B 治疗 MDR-GNB 肺部感染的临床疗效和经济学分析.
Autorzy:
高 森
田晶晶
宁艳硕
刘文静
亢宏山
Pokaż więcej
Alternatywny tytuł:
Clinical Efficacy and Economic Analysis of Reduning Injection Combined with Meropenem and Polymyxin B in the Treatment of Pulmonary Infection of MDR-GNB.
Źródło:
Evaluation & Analysis of Drug-Use in Hospitals of China. 2023, Issue 11, p1309-1316. 5p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Integrated metabolomic and transcriptomic analyses of the synergistic effect of polymyxin-rifampicin combination against Pseudomonas aeruginosa.
Autorzy:
Mahamad Maifiah MH; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 3052, Australia.; International Institute for Halal Research and Training, International Islamic University Malaysia, 50728, Kuala Lumpur, Malaysia.
Zhu Y; Infection Program and Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia.
Tsuji BT; Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA.
Creek DJ; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 3052, Australia.
Velkov T; Department of Biochemistry and Pharmacology, University of Melbourne, Melbourne, VIC, 3010, Australia.
Li J; Infection Program and Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia. .
Pokaż więcej
Źródło:
Journal of biomedical science [J Biomed Sci] 2022 Oct 30; Vol. 29 (1), pp. 89. Date of Electronic Publication: 2022 Oct 30.
Typ publikacji:
Journal Article
MeSH Terms:
Pseudomonas aeruginosa*/genetics
Polymyxin B*/pharmacology
Polymyxin B*/metabolism
Humans ; Rifampin/pharmacology ; Rifampin/metabolism ; Transcriptome ; Polymyxins/pharmacology ; Polymyxins/metabolism ; Anti-Bacterial Agents/pharmacology ; Microbial Sensitivity Tests
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Correlation between the drug concentration of polymyxin B and polymyxin B-associated acute kidney injury in critically ill patients: A prospective study.
Autorzy:
Xu Y; Surgical Intensive Care Unit (SICU), Department of General Surgery, Jinling Hospital of Nanjing Medical University, Nanjing, China.; Intensive Care Unit, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, Jiangsu, China.
Liang P; Department of Pharmacy, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, China.
Liu N; Intensive Care Unit, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, Jiangsu, China.
Dong D; Intensive Care Unit, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, Jiangsu, China.
Gu Q; Intensive Care Unit, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, Jiangsu, China.
Wang X; Surgical Intensive Care Unit (SICU), Department of General Surgery, Jinling Hospital of Nanjing Medical University, Nanjing, China.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2022 Oct; Vol. 10 (5), pp. e01010.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Acute Kidney Injury*/chemically induced
Polymyxin B*/adverse effects
Critical Illness ; Humans ; Intensive Care Units ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in haematological malignances and hematopoietic stem cell transplantation: Clinical impact of combination therapy in a 10-year Brazilian cohort.
Autorzy:
de Souza ILA; Disciplina de Infectologia, Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, Brazil.; Hcor-Hospital do Coracao, Sao Paulo, Brazil.
Cappellano P; Disciplina de Infectologia, Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, Brazil.; Fleury-Medicina e Saúde, Sao Paulo, Brazil.
Ferreira DB; Disciplina de Infectologia, Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, Brazil.; Hcor-Hospital do Coracao, Sao Paulo, Brazil.
Bergamasco MD; Disciplina de Infectologia, Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, Brazil.; Hcor-Hospital do Coracao, Sao Paulo, Brazil.
das Chagas Neto TC; Laboratório Central, Hospital São Paulo, Disciplina de Medicina Laboratorial, Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, Brazil.
Kerbauy FR; Disciplina de Hematologia e Hemoterapia, Departamento de Oncologia Clínica e Experimental, Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, Brazil.
Baiocchi OCG; Disciplina de Hematologia e Hemoterapia, Departamento de Oncologia Clínica e Experimental, Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, Brazil.
Pignatari ACC; Disciplina de Infectologia, Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 26; Vol. 19 (1), pp. e0297161. Date of Electronic Publication: 2024 Jan 26 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Klebsiella Infections*/microbiology
Bacteremia*/microbiology
Carbapenem-Resistant Enterobacteriaceae*
Hematologic Neoplasms*/therapy
Hematologic Neoplasms*/drug therapy
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Klebsiella pneumoniae ; Retrospective Studies ; Polymyxin B/therapeutic use ; Brazil/epidemiology ; Anti-Bacterial Agents/therapeutic use ; Carbapenems/therapeutic use ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A method for increasing electroporation competence of Gram-negative clinical isolates by polymyxin B nonapeptide.
Autorzy:
Qin J; Centre for Immunology and Infection Control, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia. .
Hong Y; Centre for Immunology and Infection Control, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Pullela K; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Morona R; School of Biological Sciences, Department of Molecular and Biomedical Sciences, Research Centre for Infectious Diseases, University of Adelaide, Adelaide, Australia.
Henderson IR; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Totsika M; Centre for Immunology and Infection Control, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jul 08; Vol. 12 (1), pp. 11629. Date of Electronic Publication: 2022 Jul 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Escherichia coli*
Polymyxin B*/analogs & derivatives
Polymyxin B*/chemistry
Polymyxin B*/pharmacology
Electroporation ; Polymyxins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Endotoxin removal therapy with Polymyxin B immobilized fiber column: a single center experience from EUPHAS2 registry.
Autorzy:
Forin, Edoardo (AUTHOR)
Lorenzoni, Giulia (AUTHOR)
Ferrer, Ricard (AUTHOR)
De Cal, Massimo (AUTHOR)
Zanella, Monica (AUTHOR)
Marchionna, Nicola (AUTHOR)
Gregori, Dario (AUTHOR)
Forfori, Francesco (AUTHOR)
Lorenzin, Anna (AUTHOR)
Danzi, Vinicio (AUTHOR)
Ronco, Claudio (AUTHOR)
De Rosa, Silvia (AUTHOR)
Pokaż więcej
Źródło:
Scientific Reports. 10/16/2023, Vol. 13 Issue 1, p1-14. 14p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Polymyxin B Combined with Minocycline: A Potentially Effective Combination against bla OXA-23 -harboring CRAB in In Vitro PK/PD Model.
Autorzy:
Qu X; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China.; Key Laboratory of Clinical Pharmacology of Antibiotics, Shanghai 200040, China.; National Health Commission & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.; Phase I Unit, Huashan Hospital, Fudan University, Shanghai 200040, China.
Bian X; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China.; Key Laboratory of Clinical Pharmacology of Antibiotics, Shanghai 200040, China.; National Health Commission & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai 201203, China.
Chen Y; National Health Commission & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.; Phase I Unit, Huashan Hospital, Fudan University, Shanghai 200040, China.
Hu J; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China.; Key Laboratory of Clinical Pharmacology of Antibiotics, Shanghai 200040, China.; National Health Commission & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.
Huang X; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China.; Key Laboratory of Clinical Pharmacology of Antibiotics, Shanghai 200040, China.; National Health Commission & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.
Wang Y; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China.; Key Laboratory of Clinical Pharmacology of Antibiotics, Shanghai 200040, China.; National Health Commission & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.
Fan Y; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China.; Key Laboratory of Clinical Pharmacology of Antibiotics, Shanghai 200040, China.; National Health Commission & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.
Wu H; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China.; Key Laboratory of Clinical Pharmacology of Antibiotics, Shanghai 200040, China.; National Health Commission & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.
Li X; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China.; Key Laboratory of Clinical Pharmacology of Antibiotics, Shanghai 200040, China.; National Health Commission & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.
Li Y; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China.; Key Laboratory of Clinical Pharmacology of Antibiotics, Shanghai 200040, China.; National Health Commission & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.
Guo B; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China.; Key Laboratory of Clinical Pharmacology of Antibiotics, Shanghai 200040, China.; National Health Commission & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.
Liu X; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China.; Key Laboratory of Clinical Pharmacology of Antibiotics, Shanghai 200040, China.; National Health Commission & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.
Zhang J; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China.; Key Laboratory of Clinical Pharmacology of Antibiotics, Shanghai 200040, China.; National Health Commission & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.; Phase I Unit, Huashan Hospital, Fudan University, Shanghai 200040, China.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Feb 06; Vol. 27 (3). Date of Electronic Publication: 2022 Feb 06.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Synergism*
Acinetobacter Infections/*drug therapy
Acinetobacter baumannii/*drug effects
Anti-Bacterial Agents/*pharmacology
Carbapenem-Resistant Enterobacteriaceae/*drug effects
Minocycline/*pharmacology
Polymyxin B/*pharmacology
Acinetobacter Infections/microbiology ; Anti-Bacterial Agents/pharmacokinetics ; Carbapenems/pharmacology ; Drug Therapy, Combination ; In Vitro Techniques ; Minocycline/pharmacokinetics ; Polymyxin B/pharmacokinetics ; Tissue Distribution ; beta-Lactamases/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Better efficacy of triple antibiotics therapy for human brucellosis: A systematic review and meta-analysis.
Autorzy:
Huang S; Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.
Wang H; Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.
Li F; Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.
Du L; Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.
Fan W; Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.
Zhao M; Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.
Zhen H; Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.
Yan Y; Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.
Lu M; Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.
Han X; Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.
Li Z; Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.
Li M; Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.
An S; Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.
Zhang X; Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.
Zhen Q; Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.; State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Changchun, China.
Shui T; Yunnan Center for Disease Control and Prevention, Kunming, Yunnan, China.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2023 Sep 14; Vol. 17 (9), pp. e0011590. Date of Electronic Publication: 2023 Sep 14 (Print Publication: 2023).
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug-Related Side Effects and Adverse Reactions*
Brucellosis*/drug therapy
Humans ; Reproducibility of Results ; Anti-Bacterial Agents/adverse effects ; Polymyxin B
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 7212

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies